Direkt zum Inhalt
Merck
  • Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.

Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2015-02-26)
Injae Hwang, Yoon Jeong Park, Yeon-Ran Kim, Yo Na Kim, Sojeong Ka, Ho Young Lee, Je Kyung Seong, Yeong-Jae Seok, Jae Bum Kim
ZUSAMMENFASSUNG

Firmicutes and Bacteroidetes, 2 major phyla of gut microbiota, are involved in lipid and bile acid metabolism to maintain systemic energy homeostasis in host. Recently, accumulating evidence has suggested that dietary changes promptly induce the alteration of abundance of both Firmicutes and Bacteroidetes in obesity and its related metabolic diseases. Nevertheless, the metabolic roles of Firmicutes and Bacteroidetes on such disease states remain unclear. The aim of this study was to determine the effects of antibiotic-induced depletion of Firmicutes and Bacteroidetes on dysregulation of energy homeostasis in obesity. Treatment of C57BL/6J mice with the antibiotics (vancomycin [V] and bacitracin [B]), in the drinking water, before diet-induced obesity (DIO) greatly decreased both Firmicutes and Bacteroidetes in the gut as revealed by pyrosequencing of the microbial 16S rRNA gene. Concomitantly, systemic glucose intolerance, hyperinsulinemia, and insulin resistance in DIO were ameliorated via augmentation of GLP-1 secretion (active form; 2.03-fold, total form; 5.09-fold) independently of obesity as compared with untreated DIO controls. Furthermore, there were increases in metabolically beneficial metabolites derived from the gut. Together, our data suggest that Firmicutes and Bacteroidetes potentially mediate insulin resistance through modulation of GLP-1 secretion in obesity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Fluoreszeinisothiocyanat–Dextran, average mol wt 4,000, (FITC:Glucose = 1:250)
Sigma-Aldrich
Cholesterin, Sigma Grade, ≥99%
Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Vancomycin -hydrochlorid aus Streptomyces orientalis, ≥900 μg per mg (as vancomycin base)
Sigma-Aldrich
1,4-Diamino-butan -dihydrochlorid, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Cholesterin, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
Taurocholsäure Natriumsalz Hydrat, ≥95% (HPLC)
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Creatin Monohydrat, ≥98%
Sigma-Aldrich
Cholesterin, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
1,4-Diamino-butan -dihydrochlorid, ≥98% (TLC)
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Insulin aus Rinderpankreas, ≥25 USP units/mg (HPLC), powder
Sigma-Aldrich
SyntheChol® NS0-Supplement, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
SAFC
Pflanzliches Cholesterin, SyntheChol®
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
H-89 dihydrochloride hydrate, ≥98% (HPLC), powder
Sigma-Aldrich
Cholesterin, from lanolin, ≥99.0% (GC)
Sigma-Aldrich
1,4-Diamino-butan -dihydrochlorid, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
SAFC
Cholesterin, from sheep wool, Controlled origin, meets USP/NF testing specifications